Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors and Biguanide Antidiabetic Combinations
Sodium glucose co-transporter 2 (SGLT2) inhibitors and biguanide antidiabetic combinations are used to treat type 2 diabetes. SGLT2 inhibitors lower blood glucose levels by inhibiting the reabsorption of glucose back into the blood. Biguanides, such as metformin, lower blood sugar levels and also work to decrease the amount of glucose reabsorbed. Commonly prescribed SGLT2 inhibitor and biguanide antidiabetic combinations include Invokamet (canagliflozin, metformin) and Xigduo XR (canagliflozin, metformin).
Drugs classified as Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors and Biguanide Antidiabetic Combinations are frequently used to treat the following conditions:
Click on a drug below in order to find information and discounted prices at pharmacies near you.
Synjardy Xr
Invokamet
Invokamet Xr
Xigduo Xr